Reports > Life Sciences > Drug Discovery Informatics Market Report
Drug Discovery Informatics Market Size, Share, Industry Trends and Forecast to 2033
This report provides a comprehensive analysis of the Drug Discovery Informatics market, presenting insights into market size, trends, segmentation, and forecasts for the period of 2023 to 2033.
| Metric | Value |
|---|---|
| Study Period | 2023 - 2033 |
| 2023 Market Size | $5.00 Billion |
| CAGR (2023-2033) | 6% |
| 2033 Market Size | $9.08 Billion |
| Top Companies | Thermo Fisher Scientific, Schrödinger, Inc., PerkinElmer, Certara |
| Last Modified Date | 15 Nov 2024 |
Drug Discovery Informatics Market Report (2023 - 2033)
Drug Discovery Informatics Market Overview
What is the Market Size & CAGR of Drug Discovery Informatics market in 2023?
Drug Discovery Informatics Industry Analysis
Drug Discovery Informatics Market Segmentation and Scope
Request a custom research report for industry.
Drug Discovery Informatics Market Analysis Report by Region
Europe Drug Discovery Informatics Market Report:
Europe's market, valued at USD 1.29 billion in 2023 and anticipated to grow to USD 2.35 billion by 2033, benefits from strong pharmaceutical sectors and significant governmental support for innovation in drug development.Asia Pacific Drug Discovery Informatics Market Report:
In the Asia Pacific region, the Drug Discovery Informatics market is valued at USD 0.96 billion in 2023 and is projected to reach USD 1.74 billion by 2033, reflecting robust growth opportunities driven by increasing drug development activities and supportive government initiatives.North America Drug Discovery Informatics Market Report:
North America holds the largest market share with a value of USD 1.65 billion in 2023 projected to reach USD 2.99 billion by 2033. This is attributed to the presence of major pharmaceutical and biotechnology companies and high R&D expenditures within the region.South America Drug Discovery Informatics Market Report:
The South America market, though smaller, shows promise with a 2023 market value of USD 0.41 billion growing to USD 0.74 billion by 2033. This growth is fueled by rising pharmaceutical investments and collaborations with international biopharmaceutical firms.Middle East & Africa Drug Discovery Informatics Market Report:
The Middle East and Africa market is expected to grow from USD 0.70 billion in 2023 to USD 1.27 billion in 2033, driven by increasing investments in healthcare infrastructure and growing interest from global pharmaceutical companies in the region.Request a custom research report for industry.
Drug Discovery Informatics Market Analysis By Product Type
Global Drug Discovery Informatics Market, By Product Type Market Analysis (2023 - 2033)
The product-type segment encompasses software solutions, informatics tools, and consulting services. In 2023, software solutions dominate with a market valuation of USD 1.27 billion. Informatics tools also show strong performance with projected growth, while consulting services are expected to experience a significant uptick as companies seek expert advice on emerging innovations.
Drug Discovery Informatics Market Analysis By Application Area
Global Drug Discovery Informatics Market, By Application Area Market Analysis (2023 - 2033)
Preclinical research is a major area, contributing significantly to market share, with revenues reaching USD 3.30 billion in 2023. Clinical research follows closely, reflecting a critical need for data analytics to bolster advancements in clinical trials.
Drug Discovery Informatics Market Analysis By End User
Global Drug Discovery Informatics Market, By End-User Market Analysis (2023 - 2033)
Pharmaceutical companies command a significant share of the market at 65.98% in 2023, owing to their substantial investment in drug discovery. Biotechnology firms, with a share of 25.44%, are leveraging informatics technologies to enhance their research capabilities. Research institutions represent the remaining share, focusing on innovation and development.
Drug Discovery Informatics Market Analysis By Technology
Global Drug Discovery Informatics Market, By Technology Market Analysis (2023 - 2033)
Technology in this market includes AI and machine learning, cloud computing, and bioinformatics. AI and machine learning solutions constitute around 65.98% market share, signifying a trend towards data-driven decision-making and enhancing efficiency in drug development.
Drug Discovery Informatics Market Trends and Future Forecast
Request a custom research report for industry.
Global Market Leaders and Top Companies in Drug Discovery Informatics Industry
Thermo Fisher Scientific:
A leading provider of analytical instruments, reagents, and consumables for drug discovery, facilitating the integration of informatics solutions into research.Schrödinger, Inc.:
Pioneering in computational drug discovery, offering powerful software solutions that enable predictive modeling of drug candidates.PerkinElmer:
Specializes in scientific instrumentation and software that supports drug discovery and development, enhancing process efficiency and data management.Certara:
Provides advanced pharmacokinetics and predictive modeling software, critical for informed decision-making in drug development pipelines.We're grateful to work with incredible clients.
